Please try another search
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Name | Age | Since | Title |
---|---|---|---|
Thomas A. McDonald | - | 2017 | Independent Non-Executive Director |
David James Heaney | 77 | 2006 | Independent Non-Executive Chairman |
James S. McBrayer | 56 | 2008 | CEO, MD, Company Secretary & Director |
Dianne M. Angus | 62 | 2021 | Independent Non-Executive Director |
Kevin M. J. Barrow | - | 2022 | Independent Non-Executive Director |
Gregory G. King | - | 2022 | Independent Non-Executive Director |
John Wigglesworth | - | 2024 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review